Fact CheckerSign in

NCT07726082Recruiting

Micro-choice-based Intervention for Multicausal Fatigue

Micro-choice-based Intervention for Multicausal Fatigue: Proof of Concept Study

Source: ClinicalTrials.gov · Last updated 18 Aug 2026

Brief summary (registry, in English)

This proof-of-concept study aims to evaluate the feasibility, acceptability, and potential benefits of a novel multimodal approach: the micro-choice-based intervention.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
24 (estimated)
First submitted
21 Jul 2026
Start date
13 Aug 2026
Primary completion date
Aug 2027
Lead sponsor
University Hospital, Basel, Switzerland
NCT number
NCT07726082

What you commit to

  • Study type: Interventional
  • Planned participants: 24
  • From 13 Aug 2026 to the primary completion date, Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Lack the cognitive capacity to understand study procedures (e.g. due to dementia)
  • Present with severe medical conditions that may interfere with participation (e.g., advanced organ failure, uncontrolled inflammatory or autoimmune diseases, or severe psychiatric disorders)
  • Have active cancer or are currently undergoing cancer treatment
  • Are deemed incompatible with group participation during the preparation phase, based on a team assessment. Reasons for exclusion based on group incompatibility include:
    • Need for a level of individual therapeutic support that exceeds what can be provided in a group setting; b) Refusal to engage in group-based therapy; c) Personality traits that are considered incompatible with group dynamics; d) Failure to attend the mandatory preparatory webinar (no-show is considered a no-go); e) Other significant reasons as determined by the therapeutic team)

Other

  • Have insufficient proficiency in German to complete study-related questionnaires

Who the study is looking for

  • \- Experiencing persistent fatigue with a significant impact on daily functioning (Chalder Fatigue- Scale bimodal ≥ 4)

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital Basel
Coordinator of this site? Confirm its status
BaselSwitzerlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.